Premium
Limitations of Point‐of‐Care Testing in the ED or ICU: A Role for Regional Centralized Toxicology Laboratories
Author(s) -
Wu A H B
Publication year - 2010
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2010.45
Subject(s) - clinical toxicology , clinical pharmacology , intensive care unit , medicine , intensive care medicine , medical emergency , medical physics , toxicology , pharmacology , emergency medicine , biology
Although speed in reporting results of clinical laboratory testing for emergency department and intensive care unit patients is always desirable, for clinical toxicology purposes, tests using immunoassays from the central laboratory or point‐of‐care devices do not have adequate performance or cover the menu of drugs needed to meet clinical standards. Therefore, a regional toxicology laboratory using liquid chromatography–mass spectrometry is desirable for accurate and comprehensive coverage of drug testing. Clinical Pharmacology & Therapeutics (2010) 88 3, 295–298. doi: 10.1038/clpt.2010.45